Tandem
-56%
est. 2Y upside i
Tandem is building the world's largest network of doctors, patients, and first-party data and applying AI to every step of bringing new therapies to market. Our first product ensures people get life-changing therapeutics as quickly and cheaply as possible. Founded by product leaders from Oscar Health.
Rank
#3351
Sector
HealthTech
Est. Liquidity
~3Y
Data Quality
Data: MediumThe equity upside over 2 years is deeply negative across all scenarios due to the 20x entry multiple and critical incumbent threat.
Last updated: July 3, 2026
10x exit multiple driven by IPO window and category leadership yields ~$970M exit; after $160M preferred, common recovers $810M, a 19% loss versus entry.
6x exit multiple converging to public comps gives ~$582M exit; after preferred, common gets $422M, a 57.8% loss.
3x exit multiple from competitive compression yields ~$291M exit; after preferred, common recovers $131M, an 86.9% loss.
Preference Stack Risk
moderateFunding Intensity
16%Total preferred stock of $160M represents 16% of the $1B valuation, creating a moderate overhang in downside scenarios.
Dilution Risk
lowThe recent $123M Series B in May 2026 likely provides more than 2 years of runway, reducing near-term dilution risk.
Secondary Liquidity
noneNo secondary market trades or implied valuation are reported; liquidity is expected only via IPO or acquisition.
Core — 7 roles
- Chief of Staff · New York office
- Legal Counsel · New York office
- People Operations · New York office
- +4 more →
Engineering — 7 roles
- Applied AI Engineer · New York office
- Engineering Internship · New York office
- Growth Engineer · New York office
- +4 more →
Growth & GTM — 6 roles
- Commercialization Lead · New York office
- Enterprise Growth Associate · New York office
- Life Sciences Strategy Lead · New York office
- +3 more →
Operations & Scaling — 4 roles
- Clinical Intelligence Associate · New York office
- Clinical Intelligence Strategy & Operations · New York office
- Operations Scaling · New York office
- +1 more →
Data — 2 roles
- Data & Analytics Engineer · New York office
- Data Scientist · New York office
Product & Design — 2 roles
- Brand Designer · New York office
- Product Designer · New York office
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Tandem's data — designed to show you've done your homework.
- 1
“How does the company plan to defend against Epic Systems embedding prior authorization for free, and what is the concrete competitive response?”
- 2
“What are the unit economics of a pharmaceutical partnership, and how scalable is the data monetization model given regulatory constraints?”
- 3
“Given the high current valuation, what is the realistic timeline to an IPO or acquisition, and what milestones would trigger a down round or equity impairment?”
Community
Valuation Sentiment
Our model estimates -56% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.